Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Camcevi (leuprolide mesylate) for the Treatment of Advanced Prostate Cancer

drugsMay 27, 2021

Tag: advanced prostate cancer , leuprolide mesylate , GnRH

PharmaSources Customer Service